BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nitroblue Tetrazolium

the latter causing neutrophils to reduce the dye; used to confirm diagnosis of chronic granulomatous disease.

300+ PubMed studies analyzed · Evidence Score: 46.2

Research Domains

Nitroblue Tetrazolium has been studied across 16 research domains including 🫁 Respiratory, 😴 Sleep, 🔥 Metabolic, 🔬 Oncology, 🫘 Kidney. The primary research focus is 🫁 Respiratory with 6% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nitroblue Tetrazolium, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Tannins
2 shared targets
artemisia
3 shared targets
commiphora
3 shared targets
taxillus
2 shared targets
polygonum
3 shared targets
scutellaria
3 shared targets
apis
3 shared targets
bupleurum
3 shared targets
coix
3 shared targets
leonurus
3 shared targets
Loading evidence profile...

This evidence profile for Nitroblue Tetrazolium is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.